Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$144.95 - $152.29 $232 Million - $244 Million
1,600,600 Added 1497.29%
1,707,500 $259 Million
Q2 2022

Aug 15, 2022

BUY
$83.14 - $145.99 $8.89 Million - $15.6 Million
106,900 New
106,900 $15.6 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jet Capital Investors L P Portfolio

Follow Jet Capital Investors L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jet Capital Investors L P, based on Form 13F filings with the SEC.

News

Stay updated on Jet Capital Investors L P with notifications on news.